Questions, Answers & Key Concepts
2026-2027
100 Questions
100% VERIFIED
Introduction
The IDACS Exam 2026/2027 is a comprehensive professional certification assessment designed to
evaluate expertise in infectious disease control and prevention. This examination encompasses
eight essential domains: Infectious Disease Pathophysiology, Infection Prevention and Control,
Antimicrobial Stewardship and Pharmacology, Epidemiology and Surveillance, Isolation
Precautions and PPE, Laboratory Diagnostics and Specimen Collection, Patient Education and
Community Health, and Regulatory Compliance and Reporting. Mastery of these domains is critical
for healthcare professionals responsible for preventing healthcare-associated infections, managing
outbreaks, and ensuring compliance with evidence-based infection control standards. Success in
this assessment validates professional competence in infectious disease control operations and
reinforces the highest standards of patient safety and public health protection.
Q1. What is the primary mechanism by which bacteria develop resistance to beta-lactam
antibiotics?
A. Increased efflux pumps that actively remove antibiotics from the cell
B. Production of beta-lactamase enzymes that hydrolyze the antibiotic's beta-lactam
ring
C. Mutation of ribosomal RNA to prevent protein synthesis inhibition
D. Alteration of the bacterial cell wall to prevent antibiotic entry
Rationale: Beta-lactamase enzymes break down the beta-lactam ring structure, rendering antibiotics
like penicillins and cephalosporins ineffective. While altered permeability and efflux pumps are
resistance mechanisms, they are not the primary mechanism for beta-lactams. Ribosomal mutation
relates to protein synthesis inhibitors, not beta-lactams.
Q2. Which stage of the infectious disease process occurs when the pathogen multiplies and
causes tissue damage?
A. Illness stage
B. Prodromal stage
C. Convalescence stage
, D. Incubation period
Rationale: The illness stage is when specific signs and symptoms manifest as the pathogen causes tissue
damage and the immune response intensifies. The incubation period is asymptomatic multiplication, the
prodromal stage has nonspecific symptoms, and convalescence is recovery.
Q3. What is the key difference between endotoxins and exotoxins produced by pathogenic
bacteria?
A. Endotoxins cause localized infections only, while exotoxins cause systemic disease
B. Endotoxins are produced only by viruses, while exotoxins are bacterial
C. Endotoxins are heat-labile proteins, while exotoxins are heat-stable
D. Endotoxins are lipopolysaccharides released when gram-negative bacteria die, while
exotoxins are proteins actively secreted by living bacteria
Rationale: Endotoxins (LPS) are structural components of gram-negative cell walls released upon cell
death, while exotoxins are potent proteins secreted by both gram-positive and gram-negative bacteria.
Endotoxins are not viral, are heat-stable (not labile), and can cause systemic effects like septic shock.
Q4. Which immunoglobulin is primarily responsible for the initial immune response to a
new infection?
A. IgE
B. IgG
C. IgM
D. IgA
Rationale: IgM is the first antibody produced during primary immune response, appearing within days
of infection. IgG develops later and provides long-term immunity, IgA is found in mucosal secretions, and
IgE mediates allergic reactions and parasitic defense.
Q5. What is the significance of a biofilm in chronic infections?
A. Biofilms create a protective matrix that shields bacteria from antibiotics and host
immune defenses, making infections difficult to eradicate
B. Biofilms only form on medical devices and have no role in tissue infections
C. Biofilms enhance antibiotic penetration and increase treatment effectiveness
D. Biofilms are easily removed with standard antiseptic solutions
Rationale: Biofilms are structured communities encased in extracellular polymeric substance that
dramatically reduce antibiotic efficacy and immune clearance. They do not enhance treatment, form on
both devices and tissues, and resist standard antiseptics.
, Q6. Which type of immunity is provided by administration of immune globulin after
exposure to a pathogen?
A. Natural active immunity
B. Artificial passive immunity
C. Artificial active immunity
D. Natural passive immunity
Rationale: Artificial passive immunity involves administration of preformed antibodies (immune
globulin) providing immediate but temporary protection. Natural active occurs from infection, artificial
active from vaccination, and natural passive from maternal antibody transfer.
Q7. What is the role of quorum sensing in bacterial pathogenesis?
A. Quorum sensing allows bacteria to exchange genetic material for rapid mutation
B. Bacteria use quorum sensing to identify and attack competing bacterial species
C. Bacteria use quorum sensing to detect and avoid antibiotic molecules in the environment
D. Bacteria communicate via chemical signals to coordinate virulence factor production
and biofilm formation when population density reaches a threshold
Rationale: Quorum sensing is cell-to-cell communication that regulates gene expression based on
population density, triggering coordinated virulence. It does not detect antibiotics, exchange genes
(that's horizontal gene transfer), or identify competitors.
Q8. Which viral replication cycle results in immediate host cell lysis and release of new
virions?
A. Lytic cycle
B. Latent cycle
C. Lysogenic cycle
D. Chronic cycle
Rationale: The lytic cycle involves active viral replication culminating in host cell destruction and virion
release. The lysogenic cycle integrates viral DNA into the host genome without immediate lysis, latent
infections remain dormant, and chronic infections produce virus without cell death.
Q9. What is the primary function of Toll-like receptors (TLRs) in innate immunity?
A. Recognize pathogen-associated molecular patterns (PAMPs) and initiate
inflammatory and immune responses
B. Produce antibodies specific to bacterial surface antigens
C. Directly phagocytose and destroy invading microorganisms